TIDES Asia: Oligonucleotide and Peptide Therapeutics 2023
Industry leaders and service providers share cutting-edge content and company expertise across the oligonucleotide, peptide, mRNA and drug delivery spectrum
This event series will continue to provide cutting-edge content to the TIDES scientific community in Asia, by covering the latest developments in oligonucleotide, peptide, mRNA and genome editing therapeutic discovery, CMC/ manufacturing and delivery.
Visionary keynotes and speakers coming to Kyoto in March 2023:
Shuling Guo, PhD
Vice President, Antisense Drug Discovery
Ionis Pharmaceuticals, Inc.
Hiroaki Suga, PhD
Professor of Chemistry, School of Science
University of Tokyo, Japan
David J. Craik, PhD
Professor of Biomolecular Structure, Institute for Molecular Bioscience
University of Queensland
Vasant Jadhav, PhD
Senior Vice President, Head of RNAi Platform
Alnylam Pharmaceuticals
Takanori Yokota, MD, PhD
Professor, Neurology and Neurological Science
Tokyo Medical and Dental University
Yi Yang, PhD
Principal Scientist
Ferring Pharmaceuticals A/S
Satoshi Obika, PhD
Professor, Graduate School of Pharmaceutical Sciences
Osaka University
Click the link to see all the confirmed sponsors for the 2023 TIDES Asia Hybrid Event.